Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Trial of Efficacy and Safety of Sirolimus in Tuberous Sclerosis and LAM (TESSTAL)
This study is ongoing, but not recruiting participants.
Study NCT00490789 Information provided by Cardiff University
First Received: June 21, 2007 Last Updated: April 29, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Tuberous Sclerosis
Lymphangioleiomyomatosis
Additional conditions recognized in this trial
Sclerosis
More general conditions related to this trial
Congenital Abnormalities
Genetic Diseases, Inborn
Hamartoma
Heredodegenerative Disorders, Nervous System
Immune System Diseases
Immunoproliferative Disorders
Lymphangiomyoma
Lymphatic Diseases
Lymphatic Vessel Tumors
Lymphoproliferative Disorders
Malformations of Cortical Development
Neoplasms
Neoplasms by Histologic Type
Nervous System Diseases
Nervous System Malformations
Neurocutaneous Syndromes
Neurodegenerative Diseases
Pathologic Processes
Interventions listed in this trial
sirolimus
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Antibiotics, Antineoplastic
Antifungal Agents
Antineoplastic Agents
Immunologic Factors
Immunosuppressive Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Cardiff University
University of Nottingham
St Georges Hospital Medical School
Royal Sussex County Hospital
Wales Gene Park
The Tuberous Sclerosis Association
Wyeth
Back to top of Main Content
